Nominations
Open March 15,
2025
Selection Process & Criteria
The Dr. Paul Janssen Award for Biomedical Research is presented annually. Each year, the nominations are reviewed and awardee(s) are chosen by a Selection Committee of six to eight distinguished and independent scientists. Committee deliberations are confidential and independent of Johnson & Johnson or other outside influences. The award is a citation and a prize of $200,000.
The Selection Committee will choose a scientist (or a group of scientists), in basic or clinical research, who:
- Has made a significant contribution to research that has impacted, or has strong potential to impact, human health through the diagnosis, treatment, or prevention of disease.
- Exhibits the standards of innovation, insight, and leadership that Dr. Paul exemplified during his career.
- Provides a living example that the study of science and technology can enable or has the potential to enable extended, healthy, productive life.
- Displays a set of ethical values consistent with the Johnson & Johnson Credo and those values that guide the company.
The award can be given to a clinical or basic research scientist or group of scientists in academia, government, industry, private research institution, medical, or clinical practice. It will typically recognize an individual scientist but can be shared in circumstances in which the contributions of multiple nominees are viewed as being of similar importance. Self-nominations will not be considered.
Selection Committee
Dr. Elaine Fuchs
Dr. Elaine Fuchs
Rebecca C. Lancefield Professor Investigator, Howard Hughes Medical Institute.
Ph.D.
Jeffrey Gordon
Jeffrey Gordon
Dr. Robert J. Glaser, Distinguished University Professor, Washington University School of Medicine.
M.D.
Ruth Lehmann
Ruth Lehmann
Director and President of the Whitehead Institute for Biomedical Research at MIT, Professor of Biology.
Ph.D.
Michael Hall
Michael Hall
Professor and former Chair of Biochemistry at the University of Basel.
Ph.D.
James Allison
James Allison
Chair and Professor of Immunology, Director of the Parker Institute, MD Anderson Cancer Center.
Ph.D.
Carla Kim
Carla Kim
Professor at Harvard Medical School, Principal Investigator at the Stem Cell Program, Boston Children’s.
Ph.D.
Mary-Claire King
Mary-Claire King
Associate Director, MD/PhD Training Program, Affiliate Member, Fred Hutchinson Cancer Research.
Ph.D.